145 related articles for article (PubMed ID: 18601877)
1. [Prognostic classification of breast cancer and gene expression profiling].
Bertucci F; Finetti P; Cervera N; Birnbaum D
Med Sci (Paris); 2008; 24(6-7):599-606. PubMed ID: 18601877
[TBL] [Abstract][Full Text] [Related]
2. [DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].
Bertucci F; Viens P; Birnbaum D
Pathol Biol (Paris); 2006 Feb; 54(1):49-54. PubMed ID: 16376179
[TBL] [Abstract][Full Text] [Related]
3. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
4. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
5. Current status of prognostic profiling in breast cancer.
Pusztai L
Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
[TBL] [Abstract][Full Text] [Related]
6. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
Brenton JD; Carey LA; Ahmed AA; Caldas C
J Clin Oncol; 2005 Oct; 23(29):7350-60. PubMed ID: 16145060
[TBL] [Abstract][Full Text] [Related]
7. [Has the time arrived for gene expression use at the bedside?].
D'Hondt V; Piccart M; Sotiriou C
Bull Cancer; 2008 Mar; 95(3):336-43. PubMed ID: 18390414
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of breast cancer.
Paik S
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):59-63. PubMed ID: 16493262
[TBL] [Abstract][Full Text] [Related]
9. How to best classify breast cancer: conventional and novel classifications (review).
Charafe-Jauffret E; Ginestier C; Monville F; Fekairi S; Jacquemier J; Birnbaum D; Bertucci F
Int J Oncol; 2005 Nov; 27(5):1307-13. PubMed ID: 16211226
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling and clinical outcome in breast cancer.
Bertucci F; Finetti P; Cervera N; Maraninchi D; Viens P; Birnbaum D
OMICS; 2006; 10(4):429-43. PubMed ID: 17233555
[TBL] [Abstract][Full Text] [Related]
11. [Gene expression profiling of ER+ breast cancers: to discriminate the poor prognosis tumors or to define the most suitable treatment?].
Chanrion M; Darbon JM
Bull Cancer; 2008 May; 95(5):513-8. PubMed ID: 18541515
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in breast cancer: towards individualising patient management.
Murphy N; Millar E; Lee CS
Pathology; 2005 Aug; 37(4):271-7. PubMed ID: 16194824
[TBL] [Abstract][Full Text] [Related]
13. International Agency for Research on Cancer workshop on 'Expression array analyses in breast cancer taxonomy'.
Tavtigian SV; Pierotti MA; Børresen-Dale AL
Breast Cancer Res; 2006; 8(6):303. PubMed ID: 17096863
[TBL] [Abstract][Full Text] [Related]
14. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP
Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
[TBL] [Abstract][Full Text] [Related]
15. Gene expression predictors in breast cancer: current status, limitations and perspectives.
Desmedt C; Ruíz-García E; André F
Eur J Cancer; 2008 Dec; 44(18):2714-20. PubMed ID: 18977656
[TBL] [Abstract][Full Text] [Related]
16. A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study.
Chanrion M; Fontaine H; Rodriguez C; Negre V; Bibeau F; Theillet C; Hénaut A; Darbon JM
BMC Cancer; 2007 Mar; 7():39. PubMed ID: 17338809
[TBL] [Abstract][Full Text] [Related]
17. Critical review of microarray-based prognostic tests and trials in breast cancer.
Koscielny S
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):47-50. PubMed ID: 18197005
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic signatures in breast cancer.
Fu J; Jeffrey SS
Mol Biosyst; 2007 Jul; 3(7):466-72. PubMed ID: 17579771
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic and predictive impact of protein expression profiling in high risk breast cancer patients treated with high-dose chemotherapy].
Diallo-Danebrock R; Ting E; Gluz O; Herr A; Mohrmann S; Geddert H; Gabbert HE; Nitz U; Poremba C
Verh Dtsch Ges Pathol; 2007; 91():187-96. PubMed ID: 18314614
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
